Arbitration decisions, it turns out, are like cockroaches. They’re very hard to kill.  It’s a long held truism in the legal ...

Schwartz's background as a physician with plenty of government service experience will likely be popular among lawmakers.

This week on "The Readout LOUD," a pancreatic cancer breakthrough and new hope for an off-the-shelf CAR-T treatment in ...

Kennedy Jr. returned to Capitol Hill Thursday, where he defended the administration’s efforts to fight health care fraud and ...

RFK Jr. will have to walk a careful line between touting his MAHA wins and avoiding talking about his politically divisive ...

Scientists are raising a provocative hypothesis about GLP-1 drugs for obesity: Perhaps targeting the GLP-1 hormone isn't ...

Also, a sweeping Cochrane review is fueling fresh debate over amyloid-targeting Alzheimer’s drugs. And more.  The Food and ...

Theresa Gaffney is the lead Morning Rounds writer and reports on health care, new research, and public policy, with a ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall ...

The FDA will convene an outside panel of advisers to discuss whether to allow compounding pharmacies to manufacture certain ...

CMS may change breakthrough device payments, Zealthy's legal troubles, and more.

Kennedy Jr. has a delicate task ahead of him as he heads to Capitol Hill to testify about the fiscal 2027 budget request: ...